IP Library Granted Patent US 6,987,014
Granted Patent B2
US 6,987,014 · App. 09/784,340 · Granted Jan 17, 2006

Isolated nucleic acid molecules encoding human drug metabolizing proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,987,014
App. No.
09/784,340
Granted
Jan 17, 2006
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the drug-metabolizing enzyme peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the drug-metabolizing enzyme peptides, and methods of identifying modulators of the drug-metabolizing enzyme peptides.

Claims (12)

1. A nucleic acid vector comprising the nucleic acid molecule of SEQ ID NO: 1 or SEQ ID NO: 3.

2. A host cell containing the vector of claim 1 .

3. A process for producing a polypeptide comprising SEQ ID NO: 2, the process comprising culturing the host cell of claim 2 under conditions sufficient for the production of said polypeptide, and recovering said polypeptide from the host cell.

4. An isolated polynucleotide consisting of a nucleotide sequence set forth in SEQ ID NO: 1.

5. An isolated polynucleotide consisting of a nucleotide sequence set forth in SEQ ID NO: 3.

6. A vector according to claim 1 , wherein said vector is selected from the group consisting of a plasmid, virus, and bacteriophage.

7. A vector according to claim 1 , wherein said isolated nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that the protein of SEQ ID NO: 2 may be expressed by a cell transformed with said vector.

8. A vector according to claim 7 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

9. An isolated nucleic acid molecule consisting of a nucleotide sequence that is completely complementary to a nucleotide sequence consisting of SEQ ID NO: 1 or SEQ ID NO: 3.

10. An isolated polynucleotide comprising a nucleotide sequence set forth in SEQ ID NO: 1.

11. An isolated polynucleotide comprising a nucleotide sequence set forth in SEQ ID NO: 3.

12. An isolated nucleic acid molecule consisting of a nucleotide sequence that is completely complementary to a nucleotide sequence comprising SEQ ID NO: 1 or SEQ ID NO: 3.

Assignments (4)
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2004
From: PE CORPORATION (NY)
To: APPLERA CORPORATION
Reel/Frame 014615/0004 →